Day: June 9, 2022

Figure 1 Figure 1. Geophysical responses at Lacsha including IP Chargeability, Resistivity, and Magnetic responses defining four priority target areas, which are highlighted as circular dashed lines.Figure 2 Figure 2: Talus copper, molybdenum, zinc, and lead geochemistry at Lacsha, showing patterns typically seen in certain porphyry deposits; anomalous copper and molybdenum high and lead-zinc low. Four targets are highlighted as circular dashed lines.VANCOUVER, British Columbia, June 09, 2022 (GLOBE NEWSWIRE) — Latin Metals Inc. (“Latin Metals” or the “Company”) – (TSXV: LMS) OTCQB: LMSQF) is pleased to announce the results of the Induced Polarization (“IP”) survey at its 100% own Lacsha project, located in the Coastal Copper Belt, Peru. The objective of the recently completed survey was to determine the distribution...

Patent covers composition and methods of treating degenerative diseases via administration of IL-4 and IL-13 Empowered SuperkinesDelivery of selected Bcl-2 family of proteins can prevent cell death, repair cell damage and restore cellular function in various diseases.TORONTO and HOUSTON, June 09, 2022 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or “the Company”) (NASDAQ: MDNA TSX: MDNA), a clinical stage immunotherapy company, today announced that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11,352,402 titled, “Interleukin-4 Receptor-Binding Fusion Proteins And Uses Thereof.” The patent provides intellectual property (IP) protection for composition and methods of treating degenerative diseases via administration of a fusion protein comprising an IL-4 or IL-13 Superkine and an anti-apoptotic...

Vancouver, BC, June 09, 2022 (GLOBE NEWSWIRE) — Rockridge Resources Ltd. (TSX-V: ROCK) (OTCQB: RRRLF) (Frankfurt: RR0) (“Rockridge” or the “Company”) is pleased to announce that its fully funded Summer 2022 diamond drill program is set to commence in mid-July at the Knife Lake Copper VMS Project located in Saskatchewan, Canada (the “Knife Lake Project” or “Property”). Using the results and interpretation from the 2021 geophysical programs, as well as the 2021 drill and field programs, the upcoming program will focus on Geophysical VTEM targets at the Gilbert Lake zones. Furthermore, the Company is evaluating other targets across the property as well as infill and expansion drill targets at the deposit. The Knife Lake Project, consisting of 82 claims totaling 56,865 hectares (140,516 acres), is an advanced-stage copper, silver,...

Exclusive distribution agreement for initial term of three years Leader Life Sciences commits to minimum purchase of 8 Unyvero systems during initial term    Leader Life Sciences to seek regulatory clearance for Unyvero products in U.A.E. and QatarROCKVILLE, Md., June 09, 2022 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, announced today that its subsidiary Curetis GmbH has entered into a distribution agreement with Leader Life Sciences via their trading company Leader Medical Supplies Trading LLC, part of the Leader Healthcare Group, for distribution of Unyvero systems in the United Arab Emirates and Qatar. Leader Healthcare Group is one of the Middle East region’s leading distributors and...

PHILADELPHIA, June 09, 2022 (GLOBE NEWSWIRE) — Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system disorders, today announced that Simona King, chief financial officer of Passage Bio, will participate in a fireside chat at the upcoming Goldman Sachs 43rd Annual Global Healthcare Conference being held from June 13-16, 2022 in Rancho Palos Verdes, CA. Format: Fireside Chat Date: Thursday, June 16, 2022Time: 8:40 a.m. PT (11:40 a.m. ET) A live webcast of the event will be available on the Investors & Media section of Passage Bio’s website at investors.passagebio.com. A replay of the presentation will be available for 30 days following the events. About Passage Bio Passage Bio (Nasdaq: PASG) is a clinical-stage genetic medicines...

Figure 1 MD-SOQUEM AllianceFigure 2 High Grade Gold DiscoveryFigure 3 Lelievre North-WestFigure 4 Lelievre Showing ExtensionMONTREAL, June 09, 2022 (GLOBE NEWSWIRE) — Midland Exploration Inc. (“Midland”) (TSX-V: MD) is pleased to announce the start of an important exploration program targeting Cu-Zn-Co-Ag-Au / Zn-Pb-Cu-Ag-Au volcanogenic massive sulphides (“VMS”) in the Labrador Trough, Nunavik. This second exploration program will be conducted under the strategic alliance concluded between Midland and SOQUEM       (the “Alliance”). The 2022 exploration program will consist of two phases of prospecting, each lasting three weeks, scheduled from mid-June to mid-August. Several new targets for 2022 and follow-up of 2021 discoveries Following execution of the Alliance, compilation work was undertaken to cover the Labrador...

SAN FRANCISCO, June 09, 2022 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq: OLMA) and Aurigene Discovery Technologies Limited (“Aurigene”) today announced an exclusive global license agreement to research, develop and commercialize novel small molecule inhibitors of an undisclosed oncology target. Under the terms of the agreement, Olema will make an upfront licensing payment of $8 million for rights to a pre-existing Aurigene program. Aurigene will be eligible for up to $60 million in potential clinical development and regulatory milestones and up to $370 million in potential commercial milestones, as well as royalties ranging from the mid-single digits to the low double digits based on annual net sales. During the research term, Olema will contribute funding to Aurigene to facilitate ongoing...

IPA to request a Probiotic FDA Town Hall VANCOUVER, British Columbia, June 09, 2022 (GLOBE NEWSWIRE) — Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), subsidiary KGK Science Inc. applauds the efforts on the part of U.S. Food and Drug Administration (“FDA” or the “Agency”) to release the recent New Dietary Ingredient (“NDI”) enforcement draft guidance, which is part one of a multipart series of NDI guidance documents the FDA announced during a round table discussion at the IPA World Congress + Probiota Americas. According to FDA, the recent enforcement discretion guidance on late submissions of NDI notifications, released on May 19, 2022, was in response to its commitment in the Fall of 2021 to update guidelines in 2022. Instead of releasing a single guidance document containing...

Co-located Graphene Council Commercialization Conference to highlight materials innovation VANCOUVER, British Columbia, June 09, 2022 (GLOBE NEWSWIRE) — HydroGraph Clean Power Inc. (HG.CN) (the “Company” or “HydroGraph”), a commercial manufacturer of high-quality nanomaterials and alternative-energy fuels, has announced today that they will be presenting its innovative graphene product at the upcoming Advanced Materials Show and co-located Graphene Council Commercialization Conference. The shows will take place in Birmingham, UK from Tuesday, June 28-Thursday, June 30. HydroGraph will be featured at Advanced Materials at stand 18-101. Dr. Ranjith Divigalpitiya, HydroGraph chief science officer will lead a roundtable discussion on, “Understanding the Environmental Impact of Graphene-Related Materials.” “We are very excited for the...